33 results
diagnosis management pharmacology sle algorithm erythematosus systemic druginduced comparison differential medications oncology syndrome workup classification dermatology drugs hcq hepatology hydroxychloroquine
Managing warfarin INR Warfarin dosage must be individualized according to the patient's response to the drug, and
For most indications ... #pharmacology #treatment ... #medications #table ... decisionaid #cardiology #hematology
CNS Manifestations of Systemic Lupus Erythematosus (SLE) Clinical Manifestations: Demyelinating Syndrome, Headache, Movement disorders, Seizure disorders, Aseptic
Erythematosus (SLE) Clinical ... Lumbar Puncture, EEG ... Treatment: ... CNS #neurology #rheumatology ... diagnosis #management #treatment
Hydroxychloroquine Serum Measurement in SLE • Terminal elimination half-life = 40 days ([HCQI reflects long-term intake)
200ng/mL Best indications ... Special cases (e.g ... Measurement #SLE #rheumatology ... pharmacology #levels #lupus
Summary of Coagulation Deficiencies Inherited: • Hemophilia A - Deficiency of Factor VIII • Hemophilia B -
Malabsorption (e.g ... Anticoagulant Medications ... warfarin, DOACs (e.g ... Deficiencies #Summary #table ... comparison #diagnosis #hematology
Systemic Lupus Erythematosus (SLE) - Diagnosis and Management Summary • Epidemiology: 10-180/100,000, Typically Age 20-40, F:M
Systemic Lupus Erythematosus ... 40, F:M 9:1 • Clinical ... , oral ulcers, Lupus ... life-threatening • Treatment ... Management #Summary #rheumatology
Consensus Indications for Irradiated RBC Transfusions: Cellular blood components are irradiated for the prevention of TA-GVHD. Transfused
Consensus Indications ... antithymocyte globulin, etc ... HLA-selected products (e.g ... #Transfusion #Indications ... #Hematology #BloodBank
Drug Induced Lupus vs SLE Drug Induced Lupus (DIL): • Epidemiology: -10% of all lupus cases, drug-dependent,
to 1:1 F:M • Clinical ... 40, F:M 9:1 • Clinical ... life-threatening • Treatment ... sle #comparison #table ... #rheumatology #
Hydroxychloroquine - Risks and Benefits in Lupus Benefits: ↓ Disease activity, ↓ Flare, ↓ Damage, ↓ Corticosteroid dose,
and Benefits in Lupus ... - Prolonged QTc ... recommended with other medications ... Risks #Benefits #Lupus ... #sideeffects #rheumatology
Macrophage Activation Syndrome (MAS) Classified among the secondary or acquired forms of haemophagocytic lymphohistiocytosis (sHLH) What? A subset of
disease • Systemic lupus ... SJIA], systemic lupus ... Treatment: • Corticosteroids ... Diagnosis #Management #Hematology ... #Rheumatology
Antinuclear antibodies and Systemic lupus Anti-dsDNA 60-80% Association with disease activity (when with Farr assay) and lupus nephritis. Can
antibodies and Systemic lupus ... Farr assay) and lupus ... -15% If SLE is clinically ... erythematosus #diagnosis #rheumatology ... #table #ANA
No results found for "ECG qtc table treatment hematology indications clinical rheumatology lupus"
Try removing search terms or sorting by relevance
Or Upload an image for you and others searching for #ECG #qtc #table #treatment #hematology #indications #clinical #rheumatology #lupus